Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 55 citing articles:

Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Zhilei Wang, Yuchen Li, Wenhao Liao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 79
The potential of probiotics in the amelioration of hyperuricemia
Hongyuan Zhao, Zhaoxin Lu, Yingjian Lu
Food & Function (2022) Vol. 13, Iss. 5, pp. 2394-2414
Closed Access | Times Cited: 66
The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury
Eslam E. Abd El-Fattah, Sameh Saber, Ahmed A.E. Mourad, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112628-112628
Open Access | Times Cited: 57
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
Sameh Saber, Eslam E. Abd El-Fattah, A. M. Abdelhamid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114196-114196
Open Access | Times Cited: 23
Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis
Rasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel‐Reheim, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis
Mahmoud E. Youssef, Eslam E. Abd El-Fattah, A. M. Abdelhamid, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 46
Statins as anti-pyroptotic agents
Masoomeh Khalifeh, Peter E. Penson, Maciej Banach, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 5, pp. 1414-1417
Open Access | Times Cited: 41
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis
Mohamed Nasr, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113409-113409
Closed Access | Times Cited: 35
Ambroxol, a mucolytic agent, boosts HO‐1, suppresses NF‐κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis
Simona Cavalu, Hossam Sharaf, Sameh Saber, et al.
The FASEB Journal (2022) Vol. 36, Iss. 9
Open Access | Times Cited: 32
Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need
Mona H. Zohny, Simona Cavalu, Mahmoud E. Youssef, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112723-112723
Open Access | Times Cited: 29
Ganetespib (STA-9090) augments sorafenib efficacy via necroptosis induction in hepatocellular carcinoma: Implications from preclinical data for a novel therapeutic approach
Sameh Saber, Alexandru Madalin Hasan, Osama A. Mohammed, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114918-114918
Open Access | Times Cited: 18
Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis
Yang Ding, Zixu Wang, Yaoxing Chen, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2215-2227
Open Access | Times Cited: 17
Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring
Sajida Maryam, Katarzyna Krukiewicz, Ihtisham Ul Haq, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3127-3127
Open Access | Times Cited: 16
Itraconazole halts hepatocellular carcinoma progression by modulating sonic hedgehog signaling in rats: A novel therapeutic approach
Osama A. Mohammed, Ahmed S. Doghish, Lobna A. Saleh, et al.
Pathology - Research and Practice (2024) Vol. 253, pp. 155086-155086
Closed Access | Times Cited: 5
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis
A. M. Abdelhamid, Mahmoud E. Youssef, Simona Cavalu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Rosuvastatin suppresses TNF-α-induced matrix catabolism, pyroptosis and senescence via the HMGB1/NF-κB signaling pathway in nucleus pulposus cells
Weijian Chen, Zhihuai Deng, Jianxiong Zhu, et al.
Acta Biochimica et Biophysica Sinica (2023)
Open Access | Times Cited: 14
Targeting the AMPK/Nrf2 Pathway: A Novel Therapeutic Approach for Acute Lung Injury
Qianxia Huang, Yingcong Ren, Ping Yuan, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 4683-4700
Open Access | Times Cited: 4
Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib)
Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, et al.
Life Sciences (2024) Vol. 354, pp. 122966-122966
Open Access | Times Cited: 4
Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products
Ling Dong, Fengying Dong, Pingping Guo, et al.
Phytomedicine (2025) Vol. 138, pp. 156402-156402
Closed Access
The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis
Sameh Saber, Galal Yahya, Naglaa A. Gobba, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 3443-3463
Open Access | Times Cited: 31
Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis
Ahmed A. Shaaban, A. M. Abdelhamid, Mohamed M.Y. Kaddah, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113247-113247
Closed Access | Times Cited: 19
Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study
Fares E.M. Ali, Islam M. Ibrahim, Osama M Ghogar, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 6, pp. 1026-1053
Open Access | Times Cited: 12
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Mohannad Mohammad S. Alamri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1080-1080
Open Access | Times Cited: 12
Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach
Eslam E. Abd El-Fattah, Amr Y. Zakaria
International Immunopharmacology (2022) Vol. 109, pp. 108889-108889
Closed Access | Times Cited: 18
NLRP3 inflammasome in digestive diseases: From mechanism to therapy
Rui Qiang, Yanbo Li, Xin-can Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top